Urology · 1994
Chronic hematospermia: assessment by transrectal ultrasound.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Worischeck J H, Parra R O
Аннотация
OBJECTIVE: To evaluate transrectal ultrasound in the assessment of chronic hematospermia.
METHODS: Twenty-six patients aged between twenty-five and seventy-seven years (mean, 55.6 years) presenting with persistent hematospermia of an average duration of 10.2 months (range, 3 to 20 months) underwent transrectal ultrasound. Twenty-five asymptomatic men aged thirty-nine to eighty-two years (mean, 63 years) self-referred to our institution seeking transrectal ultrasound as a screening method for prostate cancer and with no previous history of hematospermia were used as controls.
RESULTS: Significant sonographic findings not present in the control group were detected in 24 patients with hematospermia. These consisted of dilated seminal vesicles in 8, ejaculatory duct cysts in 4, ejaculatory or seminal vesicle calculi in 4, the presence of ejaculatory duct and seminal vesicle dilatation in 4, seminal vesicle cysts with ipsilateral renal agenesis and absence of the vas in 2, and an intraprostatic müllerian duct remnant in 2. Of the patients having biopsies, none was found to have malignancy.
CONCLUSIONS: Transrectal ultrasound is the imaging modality of choice in the assessment of chronic hematospermia.
METHODS: Twenty-six patients aged between twenty-five and seventy-seven years (mean, 55.6 years) presenting with persistent hematospermia of an average duration of 10.2 months (range, 3 to 20 months) underwent transrectal ultrasound. Twenty-five asymptomatic men aged thirty-nine to eighty-two years (mean, 63 years) self-referred to our institution seeking transrectal ultrasound as a screening method for prostate cancer and with no previous history of hematospermia were used as controls.
RESULTS: Significant sonographic findings not present in the control group were detected in 24 patients with hematospermia. These consisted of dilated seminal vesicles in 8, ejaculatory duct cysts in 4, ejaculatory or seminal vesicle calculi in 4, the presence of ejaculatory duct and seminal vesicle dilatation in 4, seminal vesicle cysts with ipsilateral renal agenesis and absence of the vas in 2, and an intraprostatic müllerian duct remnant in 2. Of the patients having biopsies, none was found to have malignancy.
CONCLUSIONS: Transrectal ultrasound is the imaging modality of choice in the assessment of chronic hematospermia.